Menlo Park, CA, United States of America

Liposome Technology, Inc.


USPTO Granted Patents = 38

Trademarks = 2

Forward Citations = 5,676

Loading Chart...
Loading Chart...

31 inventors (with patents filed for the assignee):

goldMedal Francis J Martin (12 out of 55 patents)

silverMedal Ramachandran Radhakrishnan (9 out of 24 patents)

bronzeMedal Robert M Abra (8 out of 12 patents)

4.  Martin C Woodle (6 out of 13 patents)

5.  Annie Yau-Young (6 out of 6 patents)

6.  Carl T Redemann (5 out of 8 patents)

7.  Paul S Uster (4 out of 4 patents)

8.  Luke S Guo (4 out of 5 patents)

9.  Jacqueline K Morano (3 out of 3 patents)

10.  Paul J Mihalko (3 out of 3 patents)

11.  Francis C Szoka, Jr (2 out of 36 patents)

12.  Samuel Zalipsky (2 out of 43 patents)

13.  Danilo D Lasic (2 out of 5 patents)

14.  Yolanda P Quinn (2 out of 3 patents)

15.  Renee Ann Tenzel (2 out of 6 patents)


Core Competencies:
Polymer Compound
Lipid-Polymer Conjugates
Bronchodilator
Microreservoir Liposome
Solid Tumor Treatment
Corticosteroid Inhalation
Sustained Release
Fungal Infections
Injectable Doxorubicin
High-Encapsulation Liposomes
Ophthalmic Liposomes
Protein-Liposome Conjugates

38 patents:

Liposome Technology, Inc. is a biopharmaceutical company based in Menlo Park, California, specializing in the development and manufacturing of liposomal drug delivery systems. The organization focuses on enhancing the efficacy and safety of therapeutic agents through innovative formulations that utilize liposomes as carriers. With a commitment to advancing drug delivery technologies, Liposome Technology aims to improve patient outcomes across various therapeutic areas, including oncology and infectious diseases.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

38 Patents

#42 in Menlo Park, CA

#2,130 in California

#9,020 in US

#17,831 in the World

Menlo Park, CA (US)
Menlo Park, CA, United States of America
Forward Citations = 5,676

31 inventors:

Please report any incorrect information to [email protected]
Loading…